Literature DB >> 12452619

Prostate-specific antigen, prostate volume and transition zone volume in Japanese patients with histologically proven benign prostatic hyperplasia.

Y Furuya1, S Ohta, N Sato, T Kotake, M Masai.   

Abstract

The relationship among age, prostate-specific antigen (PSA) level and prostate volume in Japanese patients with lower urinary tract symptoms (LUTS) and histologically proven benign prostatic hyperplasia (BPH) was examined in order to assess the utility of PSA as a predictor of prostate volume. Two hundred eighteen patients with LUTS were confirmed to have BPH by histological examination for the reason of elevated PSA and/or abnormal digital rectal examination finding. Correlation among PSA, prostate volume and transition zone volume were analyzed in patients classified into age-stratified groups. Prostate volume increased with age. Mean serum PSA increased with age, and the correlation of PSA and prostate volume was determined to be statistically significant in each cohort of age. A correlation coefficient ranged from 0.315 to 0.439. In patients with LUTS and clinical BPH, serum PSA increased with age and was related to prostate volume. PSA might be useful for therapeutic decision making for patients with symptomatic BPH.

Entities:  

Mesh:

Year:  2001        PMID: 12452619     DOI: 10.1023/a:1020539404686

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  15 in total

1.  Serum PSA adjusted for volume of transition zone (PSAT) is more accurate than PSA adjusted for total gland volume (PSAD) in detecting adenocarcinoma of the prostate.

Authors:  J Kalish; W H Cooner; S D Graham
Journal:  Urology       Date:  1994-05       Impact factor: 2.649

2.  Relationship of prostate-specific antigen and prostate volume in patients with biopsy proven benign prostatic hyperplasia.

Authors:  D A Hochberg; N A Armenakas; J A Fracchia
Journal:  Prostate       Date:  2000-12-01       Impact factor: 4.104

3.  Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia.

Authors:  C G Roehrborn; P Boyle; A L Gould; J Waldstreicher
Journal:  Urology       Date:  1999-03       Impact factor: 2.649

4.  Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia. PLESS Study Group.

Authors:  C G Roehrborn; J D McConnell; M Lieber; S Kaplan; J Geller; G H Malek; R Castellanos; S Coffield; B Saltzman; M Resnick; T J Cook; J Waldstreicher
Journal:  Urology       Date:  1999-03       Impact factor: 2.649

5.  The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group.

Authors:  J D McConnell; R Bruskewitz; P Walsh; G Andriole; M Lieber; H L Holtgrewe; P Albertsen; C G Roehrborn; J C Nickel; D Z Wang; A M Taylor; J Waldstreicher
Journal:  N Engl J Med       Date:  1998-02-26       Impact factor: 91.245

Review 6.  Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate.

Authors:  J E Oesterling
Journal:  J Urol       Date:  1991-05       Impact factor: 7.450

7.  Relationship between prostate specific antigen, prostate volume and age in the benign prostate.

Authors:  G N Collins; R J Lee; G B McKelvie; A C Rogers; M Hehir
Journal:  Br J Urol       Date:  1993-04

8.  The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen.

Authors:  M C Benson; I S Whang; C A Olsson; D J McMahon; W H Cooner
Journal:  J Urol       Date:  1992-03       Impact factor: 7.450

9.  Relationship among age, prostate-specific antigen, and prostate volume in men with lower urinary tract symptoms (LUTS) and in different groups of men with and without benign and malignant prostate diseases.

Authors:  F Di Silverio; A Sciarra; G D'Eramo; P Casale; A Loreto; F Seccareccia
Journal:  Prostate       Date:  1998-06-15       Impact factor: 4.104

10.  Correlation between serum prostate specific antigen levels and the volume of the individual glandular zones of the human prostate.

Authors:  P G Hammerer; J E McNeal; T A Stamey
Journal:  J Urol       Date:  1995-01       Impact factor: 7.450

View more
  2 in total

1.  Relationships between total/free prostate-specific antigen and prostate volume in Chinese men with biopsy-proven benign prostatic hyperplasia.

Authors:  Qiqi Mao; Xiangyi Zheng; Xiaolong Jia; Yuyong Wang; Jie Qin; Kai Yang; Yu Bai; Liping Xie
Journal:  Int Urol Nephrol       Date:  2009-02-18       Impact factor: 2.370

2.  An Analytical Study of Prostate-Specific Antigen Dynamics.

Authors:  Ernesto P Esteban; Giovanni Deliz; Jaileen Rivera-Rodriguez; Stephanie M Laureano
Journal:  Comput Math Methods Med       Date:  2016-11-13       Impact factor: 2.238

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.